These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7955264)

  • 1. Inhibition of platelet adhesion during cardiopulmonary bypass reduces postoperative bleeding.
    Uthoff K; Zehr KJ; Geerling R; Herskowitz A; Cameron DE; Reitz BA
    Circulation; 1994 Nov; 90(5 Pt 2):II269-74. PubMed ID: 7955264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass.
    Tabata S; Yamaguchi S; Nagamine H; Tomita S; Arai S; Takemura H; Watanabe G
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):289-93. PubMed ID: 15296885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators.
    Tcheng JE; Harrington RA; Kottke-Marchant K; Kleiman NS; Ellis SG; Kereiakes DJ; Mick MJ; Navetta FI; Smith JE; Worley SJ
    Circulation; 1995 Apr; 91(8):2151-7. PubMed ID: 7697843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypass.
    Carteaux JP; Roux S; Kuhn H; Tschopp T; Colombo V; Hadváry P
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):834-41. PubMed ID: 8231205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin.
    Basora M; Gomar C; Escolar G; Pacheco M; Fita G; Rodriguez E; Ordinas A
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):382-7. PubMed ID: 10468248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of ulinastatin on coagulation and platelet function in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass].
    Ji HW; Chen L
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):175-8. PubMed ID: 19537033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonorheometry assessment of platelet function in cardiopulmonary bypass patients: Correlation of blood clot stiffness with platelet integrin αIIbβ3 activity, aspirin usage, and transfusion risk.
    Viola F; Lin-Schmidt X; Bhamidipati C; Haverstick DM; Walker WF; Ailawadi G; Lawrence MB
    Thromb Res; 2016 Feb; 138():96-102. PubMed ID: 26688324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
    Kondo N; Suzuki Y; Wakayama F; Tamai Y; Ji K; Fukui K; Fukuda I
    Ann Thorac Surg; 2005 Jul; 80(1):251-7. PubMed ID: 15975376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The platelet thrombin receptor and postoperative bleeding.
    Ferraris VA; Ferraris SP; Singh A; Fuhr W; Koppel D; McKenna D; Rodriguez E; Reich H
    Ann Thorac Surg; 1998 Feb; 65(2):352-8. PubMed ID: 9485228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cardiopulmonary bypass on platelet mitochondrial respiration and correlation with aggregation and bleeding: a pilot study.
    Mazzeffi M; Lund L; Wallace K; Herrera AV; Tanaka K; Odonkor P; Strauss E; Rock P; Fiskum G
    Perfusion; 2016 Sep; 31(6):508-15. PubMed ID: 26916901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of nitric oxide on platelets when delivered to the cardiopulmonary bypass circuit.
    Lowson SM; Hassan HM; Rich GF
    Anesth Analg; 1999 Dec; 89(6):1360-5. PubMed ID: 10589608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
    Südkamp M; Mehlhorn U; Reza Raji M; Hekmat K; Easo J; Geissler HJ; Sindhu D; de Vivie R
    Thorac Cardiovasc Surg; 2002 Feb; 50(1):5-10. PubMed ID: 11847596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet anesthesia with nitric oxide with or without eptifibatide during cardiopulmonary bypass in baboons.
    Suzuki Y; Malekan R; Hanson CW; Niewiarowski S; Sun L; Rao AK; Edmunds LH
    J Thorac Cardiovasc Surg; 1999 May; 117(5):987-93. PubMed ID: 10220694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons.
    Hiramatsu Y; Gikakis N; Anderson HL; Gorman JH; Marcinkiewicz C; Gould RJ; Niewiarowski S; Edmunds LH
    J Thorac Cardiovasc Surg; 1997 Jan; 113(1):182-93. PubMed ID: 9011688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary bypass-induced coagulopathy in pediatric patients: The role of platelets in postoperative bleeding. A preliminary study.
    Di Gregorio G; Sella N; Spiezia L; Menin E; Boscolo A; Pasin L; Pittarello D; Vida V; Simioni P; Navalesi P
    Artif Organs; 2021 Aug; 45(8):852-860. PubMed ID: 33432593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nitric oxide gas on platelets during open heart operations.
    Mellgren K; Mellgren G; Lundin S; Wennmalm A; Wadenvik H
    Ann Thorac Surg; 1998 May; 65(5):1335-41. PubMed ID: 9594863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new platelet function analyzer in cardiac surgery: a comparison of modified thromboelastography and whole-blood aggregometry.
    Mengistu AM; Wolf MW; Boldt J; Röhm KD; Lang J; Piper SN
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):40-6. PubMed ID: 18249329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ?
    Boldt J; Knothe C; Welters I; Dapper FL; Hempelmann G
    Ann Thorac Surg; 1996 Jul; 62(1):130-5. PubMed ID: 8678631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental studies on platelet preservation with prostaglandin I2 and its derivative (OP-41483) during cardiopulmonary bypass].
    Takeda H
    Hokkaido Igaku Zasshi; 1989 Jul; 64(4):500-11. PubMed ID: 2511131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
    Straub A; Wendel HP; Azevedo R; Ziemer G
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.